Skip to content

Clinical observation of perioperative psychological intervention on postoperative recovery of patients undergoing radical mastectomy for breast cancer under general anesthesia: a randomized controlled trial

Clinical observation of perioperative psychological intervention on postoperative recovery of patients undergoing radical mastectomy for breast cancer under general anesthesia: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064919
Enrollment
Unknown
Registered
2022-10-21
Start date
2022-10-21
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Group 1:Perioperative psychological intervention
Group 2:Routine perioperative management

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-III grade; 2. Age 18-60 years old, breast cancer stage I-III, female; 3. Elective general anesthesia for mastectomy, signed informed consent for anesthesia.

Exclusion criteria

Exclusion criteria: 1. Combined with mental illness (such as bipolar disorder, schizophrenia or dementia) or currently receiving related treatment or psychological counseling; 2. Preoperative diagnosis of other cancers; 3. Severe organ dysfunction: severe hepatic insufficiency (Child-Pugh classification Class C), renal failure, acute coronary syndrome, severe arrhythmia, acute or decompensated heart failure; 4. Consciousness dysfunction or severe visual, auditory, language and communication impairments; 5. Exclusion of music listeners.

Design outcomes

Primary

MeasureTime frame
State-Trait Anxiety Inventory (STAI);Montgomery Depression Scale (MADRS);

Secondary

MeasureTime frame
Recovery Quality QoR-40 Score;Ramsay score/VAS score;Number of postoperative adverse events (nausea, vomiting, chills, hypoxemia, etc.);

Countries

China

Contacts

Public ContactMaoyin Zhang

The Affiliated Hospital of Xuzhou Medical University

540072028@qq.com+86 15952205566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026